The Pennant Group, Inc. - Common Stock (PNTG)

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how senior health, home he...

The Pennant Group trades at $37.10 and has moved in lockstep with the market. Its shares have returned 9.7% over the last six months while the S&P 500 has ga...

PACS Group shares have rebounded after a Medicare billing scandal, with strong Q2 earnings and Buy ratings, though DOJ and SEC investigations and shareholder lawsuits remain unresolved.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

The Pennant Group (NASDAQ:PNTG) reported second-quarter 2026 results that showed revenue and adjusted earnings growth across its home health, hospice and senior living businesses, prompting the company to raise its full-year outlook. Chief Executive Officer Brent Guerisoli said the company’s perfor

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...

Senior living provider The Pennant Group (NASDAQ:PNTG) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 37.3% year on year to $298 million...

Senior living provider The Pennant Group (NASDAQ:PNTG) will be reporting earnings this Wednesday after market hours. Here’s what to expect. The Pennant Group...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

The past six months have been a windfall for The Pennant Group’s shareholders. The company’s stock price has jumped 42.3%, hitting $41.70 per share. This was...

Guerisoli exercised stock options and immediately liquidated the position following a 57% one-year rally, while retaining ~104,000 shares worth $4.1 million.

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice i...

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...

The Pennant Group’s first quarter was met with a positive market response as the company’s non-GAAP profit exceeded expectations, despite revenue coming in s...

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...